| 标题 |
[高分]
Impact of Baseline GLP-1 Receptor Agonist Use on Albuminuria Reduction and Safety With Simultaneous Initiation of Finerenone and Empagliflozin in Type 2 Diabetes and Chronic Kidney Disease (CONFIDENCE Trial) |
| 网址 | |
| DOI |
10.2337/dc25-1673
doi
|
| 其它 |
期刊:Diabetes Care 作者:Rajiv Agarwal; Jennifer B. Green; Hiddo J.L. Heerspink; Johannes F.E. Mann; Janet B. McGill; et al 出版日期:2025-09-19 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)